Great West Life Assurance CO Amicus Therapeutics, Inc. Transaction History

Great West Life Assurance CO

$56.8 Billion
Q1 2025

A detailed history of Great West Life Assurance CO transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 81,501 shares of FOLD stock, worth $475,965. This represents 0.0% of its overall portfolio holdings.

Number of Shares

81,501

Previous 80,076 1.78%

Holding current value

$475,965

Previous $753,000 11.55%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$8.16 - $9.85 $11,628 - $14,036	1,425 Added 1.78%	81,501 $666,000
Q4 2024 Feb 13, 2025	BUY	$9.36 - $12.01 $51,685 - $66,319	5,522 Added 7.41%	80,076 $753,000
Q3 2024 Nov 13, 2024	SELL	$9.55 - $12.09 $100,752 - $127,549	-10,550 Reduced 12.4%	74,554 $798,000
Q2 2024 Aug 12, 2024	SELL	$9.04 - $11.75 $139,523 - $181,349	-15,434 Reduced 15.35%	85,104 $843,000
Q1 2024 May 13, 2024	BUY	$11.43 - $14.24 $83,484 - $104,008	7,304 Added 7.83%	100,538 $1.18 Million
Q4 2023 Feb 13, 2024	BUY	$9.97 - $14.52 $51,066 - $74,371	5,122 Added 5.81%	93,234 $1.32 Million
Q3 2023 Nov 14, 2023	SELL	$11.78 - $13.86 $6,537 - $7,692	-555 Reduced 0.63%	88,112 $1.07 Million
Q2 2023 Aug 10, 2023	BUY	$10.72 - $13.3 $72,349 - $89,761	6,749 Added 8.24%	88,667 $1.12 Million
Q1 2023 May 12, 2023	SELL	$10.91 - $13.54 $45,145 - $56,028	-4,138 Reduced 4.81%	81,918 $910,000
Q4 2022 Feb 10, 2023	BUY	$9.89 - $12.7 $483,462 - $620,826	48,884 Added 131.51%	86,056 $1.06 Million
Q3 2022 Nov 01, 2022	BUY	$9.82 - $12.75 $365,029 - $473,943	37,172 New	37,172 $387,000
Q2 2022 Aug 09, 2022	BUY	$6.23 - $11.12 $4,043 - $7,216	649 Added 5.14%	13,285 $143,000
Q1 2022 May 12, 2022	BUY	$7.89 - $12.48 $4,868 - $7,700	617 Added 5.13%	12,636 $127,000
Q4 2021 Feb 14, 2022	BUY	$9.82 - $12.44 $5,774 - $7,314	588 Added 5.14%	12,019 $139,000
Q2 2021 Aug 11, 2021	SELL	$8.71 - $10.72 $21,853 - $26,896	-2,509 Reduced 18.0%	11,431 $110,000
Q1 2021 May 17, 2021	SELL	$9.2 - $23.86 $38,143 - $98,923	-4,146 Reduced 22.92%	13,940 $137,000
Q3 2020 Nov 17, 2020	SELL	$12.89 - $15.89 $79,337 - $97,802	-6,155 Reduced 25.39%	18,086 $255,000
Q3 2020 Nov 13, 2020	BUY	$12.89 - $15.89 $79,337 - $97,802	6,155 Added 34.03%	24,241 $342,000
Q4 2019 Feb 11, 2020	BUY	$7.48 - $10.75 $33,286 - $47,837	4,450 Added 32.63%	18,086 $176,000
Q3 2019 Oct 25, 2019	SELL	$8.02 - $13.25 $96,753 - $159,848	-12,064 Reduced 46.94%	13,636 $109,000
Q2 2019 Jul 31, 2019	BUY	$10.96 - $14.4 $975 - $1,281	89 Added 0.35%	25,700 $0
Q1 2019 May 08, 2019	BUY	$10.04 - $13.92 $51,374 - $71,228	5,117 Added 24.97%	25,611 $347,000
Q2 2018 Aug 10, 2018	BUY	$13.13 - $17.09 $67,593 - $87,979	5,148 Added 33.55%	20,494 $320,000
Q1 2018 May 10, 2018	SELL	$13.76 - $17.12 $95,425 - $118,727	-6,935 Reduced 31.13%	15,346 $231,000
Q4 2017 Feb 09, 2018	BUY	$12.51 - $16.24 $98,028 - $127,256	7,836 Added 54.25%	22,281 $320,000
Q3 2017 Nov 09, 2017	BUY	$11.74 - $15.78 $169,584 - $227,942	14,445	14,445 $212,000

Others Institutions Holding FOLD

# of Institutions

315

Shares Held

319M

Call Options Held

378K

Put Options Held

575K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $1.64B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Amicus Therapeutics, Inc. Transaction History